Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Bruker Corporation (BRKR) to participate in 42nd annual J.P. Morgan Healthcare Conference, with top executives presenting on January 8th, 2024. Live webcast and replay available on the Company's Investor Relations website.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 42^nd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 8^th, 2024 at 8:15 AM Pacific Standard Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240103812532/en/

Justin Ward

Sr. Director, Investor Relations & Corporate Development

Bruker Corporation

T: +1 (978) 313-5800

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

When will Bruker Corporation participate in the 42nd annual J.P. Morgan Healthcare Conference?

Bruker Corporation will participate in the conference on Monday, January 8th, 2024.

Who will be presenting on behalf of Bruker Corporation at the conference?

Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company.

Where can I access the live audio webcast of the presentation?

The live audio webcast will be available on the Investor Relations section of the Company's website at https://ir.bruker.com.

Will there be a replay of the presentation available?

Yes, a replay of the presentation will be posted in the 'Events & Presentations' section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.